Search This Blog

Thursday, August 8, 2019

Adverum Biotechnologies EPS beats by $0.04

Adverum Biotechnologies (NASDAQ:ADVM): Q2 GAAP EPS of -$0.23 beats by $0.04.
Cash and equivalents of $97.81M.
Shares -0.32%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)